BACKGROUND: The prevalence of chronic kidney disease (CKD) is high, especially among older patients. METHODS: In order to identify risk factors for the evolution towards end-stage renal disease (ESRD), a cohort of patients ≥ 50 years of age for whom at least four serum creatinine measurements were available were selected from a primary care-based database. The slope of changes in estimated glomerular filtration rate (eGFR) (using the Modification of Diet in Renal Disease formula) was calculated, and ESRD was defined as eGFR <15 mL/min. Risk factors for ESRD were analysed using Cox regression analysis. RESULTS: The cohort included 24,682 patients (13,305 women) with a mean age at first available measurement of 64 years. During follow-up (average 7.8 years), 212 patients (0.9%) developed ESRD. The incidence of ESRD per 10,000 person-years is low and depends on baseline eGFR (Stages 0-2: 3, Stage 3A: 13, Stage 3B: 121 and Stage 4: 765). Adjusted hazard ratios (HRs) for patients with baseline eGFR in Stage 3B or 4 depended on age (HR = 0.47 or 0.41 for patients 65-79 years and HR = 0.26 or 0.32 for patients ≥ 80 years compared with patients aged 50-64 years). Females (HR = 1.48) and patients with diabetes (HR = 1.20), hypertension (HR = 1.25), high total cholesterol (HR = 1.28) or high low-density lipoprotein (LDL) cholesterol (HR = 1.39) were at higher risk for ESRD. CONCLUSIONS: Baseline eGFR, diabetes, high cholesterol, high LDL, hypertension and female gender are independent risk factors for developing ESRD. Older age at baseline predicts a lower risk.
BACKGROUND: The prevalence of chronic kidney disease (CKD) is high, especially among older patients. METHODS: In order to identify risk factors for the evolution towards end-stage renal disease (ESRD), a cohort of patients ≥ 50 years of age for whom at least four serum creatinine measurements were available were selected from a primary care-based database. The slope of changes in estimated glomerular filtration rate (eGFR) (using the Modification of Diet in Renal Disease formula) was calculated, and ESRD was defined as eGFR <15 mL/min. Risk factors for ESRD were analysed using Cox regression analysis. RESULTS: The cohort included 24,682 patients (13,305 women) with a mean age at first available measurement of 64 years. During follow-up (average 7.8 years), 212 patients (0.9%) developed ESRD. The incidence of ESRD per 10,000 person-years is low and depends on baseline eGFR (Stages 0-2: 3, Stage 3A: 13, Stage 3B: 121 and Stage 4: 765). Adjusted hazard ratios (HRs) for patients with baseline eGFR in Stage 3B or 4 depended on age (HR = 0.47 or 0.41 for patients 65-79 years and HR = 0.26 or 0.32 for patients ≥ 80 years compared with patients aged 50-64 years). Females (HR = 1.48) and patients with diabetes (HR = 1.20), hypertension (HR = 1.25), high total cholesterol (HR = 1.28) or high low-density lipoprotein (LDL) cholesterol (HR = 1.39) were at higher risk for ESRD. CONCLUSIONS: Baseline eGFR, diabetes, high cholesterol, high LDL, hypertension and female gender are independent risk factors for developing ESRD. Older age at baseline predicts a lower risk.
Authors: Juan C Duque; Laisel Martinez; Annia Mesa; Yuntao Wei; Marwan Tabbara; Loay H Salman; Roberto I Vazquez-Padron Journal: Surgery Date: 2015-05-18 Impact factor: 3.982
Authors: Michael E Seifert; Lisa de Las Fuentes; Charles Ginsberg; Marcos Rothstein; Dennis J Dietzen; Steven C Cheng; Will Ross; David Windus; Victor G Dávila-Román; Keith A Hruska Journal: Am J Nephrol Date: 2014-05-06 Impact factor: 3.754
Authors: Tara I Chang; Suying Li; Shu-Cheng Chen; Carmen A Peralta; Michael G Shlipak; Linda F Fried; Adam T Whaley-Connell; Peter A McCullough; Manjula Kurella Tamura Journal: Am J Kidney Dis Date: 2013-04 Impact factor: 8.860
Authors: Bert Vaes; Emilie Beke; Carla Truyers; Steven Elli; Frank Buntinx; Jan Y Verbakel; Geert Goderis; Gijs Van Pottelbergh Journal: BMJ Open Date: 2015-06-30 Impact factor: 2.692
Authors: Geert Goderis; Gijs Van Pottelbergh; Carla Truyers; Viviane Van Casteren; Etienne De Clercq; Carine Van Den Broeke; Frank Buntinx Journal: BMJ Open Date: 2013-12-30 Impact factor: 2.692
Authors: Stein I Hallan; Kunihiro Matsushita; Yingying Sang; Bakhtawar K Mahmoodi; Corri Black; Areef Ishani; Nanne Kleefstra; David Naimark; Paul Roderick; Marcello Tonelli; Jack F M Wetzels; Brad C Astor; Ron T Gansevoort; Adeera Levin; Chi-Pang Wen; Josef Coresh Journal: JAMA Date: 2012-12-12 Impact factor: 56.272
Authors: Gijs Van Pottelbergh; Bert Vaes; Wim Adriaensen; Cathy Matheï; Delphine Legrand; Pierre Wallemacq; Jean Marie Degryse Journal: BMC Med Date: 2014-02-12 Impact factor: 8.775